Rbf Capital, LLC Catalyst Biosciences, Inc. Transaction History

Rbf Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.49 - $1.95 $14,847 - $59,086	-30,301 Reduced 22.89%	102,095 $51,000
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $97,505 - $133,618	-25,795 Reduced 16.31%	132,396 $544,000
Q2 2021 Aug 16, 2021	BUY	$4.1 - $5.33 $648,583 - $843,158	158,191 New	158,191 $685,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Rbf Capital, LLC with notifications on news.